Lentivirus-mediated RNA silencing of c-Met markedly suppresses peritoneal dissemination of gastric cancer in vitro and in vivo

Acta Pharmacologica Sinica

Volumn 33, Issue 4, 2012, Pages 513-522

  Wang, Xiao Lei ^a   Chen, Xi Mei ^a   Fang, Jian Ping ^a   Yang, Chang Qin ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

ascites; c Met; gastric cancer; lentivirus; peritoneal dissemination; peritoneal free cancer cell; RNA interference

Indexed keywords

HERMES ANTIGEN; LENTIVIRUS VECTOR; MESSENGER RNA; MICRORNA; SCATTER FACTOR RECEPTOR; UVOMORULIN; VERY LATE ACTIVATION ANTIGEN 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCITES; CANCER CELL; CANCER GENE THERAPY; CANCER INVASION; CANCER SURVIVAL; CELL ADHESION; CELL ASSAY; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MESOTHELIUM CELL; METASTASIS INHIBITION; MOUSE; NONHUMAN; PERITONEUM CELL; PERITONEUM METASTASIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNET RING CARCINOMA; STOMACH ADENOCARCINOMA; STOMACH CARCINOMA; SURVIVAL TIME; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; WESTERN BLOTTING;

ANIMALS; CADHERINS; CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; HUMANS; LENTIVIRUS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; PERITONEUM; PROTO-ONCOGENE PROTEINS C-MET; RNA INTERFERENCE; STOMACH; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 84859600409     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2011.205     Document Type: Article

References (20)

1. Yonemura Y, Endo Y, Obata T, Sasaki T. Recent advances in the treatment of peritoneal dissemination of gastrointestinal cancers by nucleoside antimetabolites. Cancer Sci 2007; 98: 11-8. (Pubitemid 44803914)
2. Terauchi M, Kajiyama H, Yamashita M, Kato M, Tsukamoto H, Umezu T, et al. Possible involvement of TWIST in enhanced peritoneal metastasis of epithelial ovarian carcinoma. Clin Exp Metastasis 2007; 24: 329-39. (Pubitemid 47124934)
3. Li CZ, Liu B, Wen ZQ, Li HY. Inhibition of CD44 expression by small interfering RNA to suppress the growth and metastasis of ovarian cancer cells in vitro and in vivo. Folia Biol (Praha) 2008; 54: 180-6.
4. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002; 110: 673-87. (Pubitemid 35283958)
5. Jin H, Varner J. Integrins: roles in cancer development and as treatment targets. Br J Cancer 2004; 90: 561-5. (Pubitemid 38297190)
6. Knudsen BS, Vande Woude G. Showering c-MET-dependent cancers with drugs. Curr Opin Genet Dev 2008; 18: 87-96. (Pubitemid 351694452)
7. Ayhan A, Ertunc D, Tok EC, Ayhan A. Expression of the c-Met in advanced epithelial ovarian cancer and its prognostic significance. Int J Gynecol Cancer 2005; 15: 618-23. (Pubitemid 41022899)
8. Drebber U, Baldus SE, Nolden B, Grass G, Bollschweiler E, Dienes HP, et al. The overexpression of c-met as a prognostic indicator for gastric carcinoma compared to p53 and p21 nuclear accumulation. Oncol Rep 2008; 19: 1477-83.
9. Tuynman JB, Lagarde SM, Ten Kate FJ, Richel DJ, van Lanschot JJ. Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma. Br J Cancer 2008; 98: 1102-8. (Pubitemid 351399800)
10. Zeng ZS, Weiser MR, Kuntz E, Chen CT, Khan SA, Forslund A, et al. c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases. Cancer Lett 2008; 265: 258-69.
11. Sawada K, Radjabi AR, Shinomiya N, Kistner E, Kenny H, Becker AR, et al. c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion. Cancer Res 2007; 67: 1670-9. (Pubitemid 46383393)
12. Yonemura Y, Endo Y, Obata T, Sasaki T. Recent advances in the treatment of peritoneal dissemination of gastrointestinal cancers by nucleoside antimetabolites. Cancer Sci 2007; 98: 11-8. (Pubitemid 44803914)
13. Barker SD, Casado E, Gomez-Navarro J, Xiang J, Arafat W, Mahasreshti P, et al. An immunomagnetic-based method for the purification of ovarian cancer cells from patient-derived ascites. Gynecol Oncol 2001; 82: 57-63. (Pubitemid 32634954)
14. Clement JH, Schwalbe M, Buske N, Wagner K, Schnabelrauch M, Görnert P, et al. Differential interaction of magnetic nanoparticles with tumor cells and peripheral blood cells. J Cancer Res Clin Oncol 2006; 132: 287-92.
15. Ross JS, Carlson JA, Brock G. miRNA: The new gene silencer. Am J Clin Pathol 2007; 128: 830-6. (Pubitemid 350133996)
16. Orian-Rousseau V, Chen L, Sleeman JP, Herrlich P, Ponta H. CD44 is required for two consecutive steps in HGF/c-Met signaling. Genes Dev 2002; 16: 3074-86. (Pubitemid 35424194)
17. Garmy-Susini B, Varner JA. Roles of integrins in tumor angiogenesis and lymphangiogenesis. Lymphat Res Biol 2008; 6: 155-63.
18. Han SU, Lee HY, Lee JH, Kim WH, Nam H, Kim H, et al. Modulation of E-cadherin by hepatocyte growth factor induces aggressiveness of gastric carcinoma. Ann Surg 2005; 242: 676-83. (Pubitemid 41567123)
19. Lesko E, Majka M. The biological role of HGF-MET axis in tumor growth and development of metastasis. Front Biosci 2008; 13: 1271-80. (Pubitemid 351594710)
20. Li Z, Zhan W, Wang Z, Zhu B, He Y, Peng J, et al. Inhibition of PRL-3 gene expression in gastric cancer cell line SGC7901 via microRNA suppressed reduces peritoneal metastasis. Biochem Biophys Res Commun 2006; 348: 229-37. (Pubitemid 44163504)